Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × Lutetium-177 × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 9 Neuroendocrine Tumors 3 Gastro-enteropancreatic neuroendocrine tumor 2 Urogenital Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Pheochromocytoma 1 Paraganglioma 1 Oligometastatic Prostate Cancer (OMPC) 1 Neoplasm Metastasis 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Lung Neoplasms 1 Digestive System Neoplasms 1 Carcinoma, Merkel Cell 1 Carcinoma 1 Breast Neoplasms 1 Biochemically Recurrent Prostate Carcinoma 1 Advanced Gastroenteropancreatic Neuroendocrine Tumor 1

Interventions

Rituximab 47 Cyclophosphamide 39 ibrutinib 26 acalabrutinib 23 fludarabine 22 venetoclax 21 Bendamustine Hydrochloride 18 Lenalidomide 17 zanubrutinib 16 obinutuzumab 16 fludarabine phosphate 13 Magnetic Resonance Spectroscopy 13 Cytarabine 13 CT-P10 13 pirtobrutinib 12 Specimen Handling 12 Biopsy 11 glofitamab 10 Etoposide 10 Whole-Body Irradiation 8 Vincristine 8 Doxorubicin 8 Melphalan 7 brexucabtagene autoleucel 6 Peripheral Blood Stem Cell Transplantation 6 Mycophenolic Acid 6 Methotrexate 6 orelabrutinib 5 Immunotherapy, Adoptive 5 Granulocyte Colony-Stimulating Factor 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡